PALISADE™ – Placental-Derived Allograft

Placental Tissue & Safety

Palisade™ is a dual-membrane allograft made from the amniotic and chorionic membranes of the placenta. Using a proprietary tissue processing technique, it's designed as a barrier or wound cover for various clinical needs, especially moderate-to-deep wound beds.

Key highlights:

  • Utilizes structural and biochemical properties of placental tissue.
  • Placental tissue is a pristine, newly formed extracellular matrix (ECM), known as a neomatrix.
  • The amnion (fetal-facing) is thinner and more compact; the chorion (maternal-facing) is thicker and less compact.
  • Both layers include collagen fibers (Types I, III, IV, V), laminin, fibronectin, proteoglycans, and hyaluronic acid.

Tissue sourcing & safety:

  • Donated tissue is collected from fully consented mothers undergoing full-term C-sections.
  • Donors are screened according to FDA and AATB standards.
  • Tissue undergoes terminal sterilization.
  • Recovery done through FDA-regulated and accredited organizations.

Product Summary

  • Minimally manipulated, dehydrated tissues derived from human amniotic and chorionic membranes.
  • Retains structural/functional characteristics of the placental membranes.
  • Available in various sizes, terminally sterilized to a 10⁻⁶ SAL.
  • Classified under 361 HCT/Ps.
  • Intended as a biologic wound covering or skin substitute for cutaneous wounds.
  • For use by qualified healthcare professionals in physician offices, outpatient, or inpatient settings.

References: